24: Biosimilars: What Consumers Should Know
We Can Do This!
English - May 29, 2024 19:31 - 29 minutes - 26.8 MBPolitics News Government advocacy reid maki economic reform fascism workers rights womens rights sally greenberg john breyault child labor food policy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 23: The Pain Project: Alternatives to Opioids
On this health series episode of NCL’s “We Can Do this” podcast, Director of Health Policy, Robin Strongin, sits with Sarah Ikenberry, Senior Communication Advisor for the Office of Therapeutic Biologics and Biosimilars at US Food and Drug Administration, and Julie Reed, Executive Director of the Biosimilars Forum. In this podcast, Robin, Sarah and Julie discuss what biosimilars are, what they mean for patients and how biosimilars can be a cost-saving alternative for patients.
For more information on biosimilars, visit https://scriptyourfuture.org/biosimilars/.